US equities |
MU $943.03 ▼-4.65% META $769.66 ▲+3.59% NVDA $224.96 ▼-0.60% SNDK $1,425.56 ▼-4.15% AAPL $344.51 ▲+1.04% MSFT $549.75 ▲+1.59% AMD $589.38 ▼-0.82% SPCX $159.15 ▼-2.61%
FinancialContent

Articles published by Cyllene Therapeutics

News headline image
Cyllene Therapeutics Presents Interim Data from Phase 1b/2a Clinical Trial Showing EG110A Reduced Urinary Episodes in Patients with Spinal Cord Injury at the International Continence Society (ICS) Conference
From Cyllene Therapeutics
Via GlobeNewswire
News headline image
Cyllene Therapeutics Appoints Seasoned Biotech Executive Dr Marc Grasso as Chief Financial Officer
From Cyllene Therapeutics
Via GlobeNewswire
News headline image
Cyllene Therapeutics Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for EG110A in Neurogenic Detrusor Overactivity (NDO)
From Cyllene Therapeutics
Via GlobeNewswire
News headline image
Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development
From Cyllene Therapeutics
Via GlobeNewswire
Tickers NKTX
News headline image
Cyllene Therapeutics (formerly known as EG 427) Raises €33 Million Series C Financing to Advance Clinical Development of EG110A and Pipeline Expansion
From Cyllene Therapeutics
Via GlobeNewswire